Skip to main content

HHS Pans Pfizer's 'Far-Fetched' Kickback Views At High Court

Mintz Member Laurence J. Freedman spoke to Law360 about the awaited brief from the U.S. Department of Health and Human Services on whether Anti-Kickback Statute cases should show whether health care "remuneration" intentionally impacted medical decision making. Larry said, "The challenges reflect long-simmering frustration with the OIG's approach to patient assistance programs."